Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
Novartis’ Acquisition of MorphoSys
Numerix’s Acquisition of PolyPaths
Willkie Farr & Gallagher LLP served as legal counsel to Numerix, while Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel to PolyPaths. Numerix,...
ARYA Sciences Acquisition Corp IV’s Acquisition of Amicus Therapeutics’ Gene Therapy Business
Skadden, Arps, Slate, Meagher & Flom, Wilson Sonsini Goodrich & Rosati and Troutman Pepper Hamilton Sanders represented Amicus Therapeutics, while Kirkland & Ellis represented ARYA IV...
Alcon’s Acquisition of U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
Skadden, Arps, Slate, Meagher & Flom LLP advised Alcon on the deal. Alcon, the global leader in eye care dedicated to helping people see brilliantly, has...